UNSPSC 51201825: Betazole hydrochloride

This classification denotes a diagnostic reagent with the molecular formula C5H9N3.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 66ABP6C83F, chemically known as 3,5-beta-pyrazoleethylamine dihydrochloride but more generally known as betazole hydrochloride, which bears US NIH Compound Identifier 67412. The base compound, betazole, most often comes in base, dihydrochloride, and hydrochloride forms.

UNSPSC 51201825 Betazole hydrochloride is a Commodity code for pharmaceutical active ingredients and finished pharmaceutical products, though the recent state and local activity tagged to this code reflects procurement of vaccines rather than betazole specifically. State and local health departments and related agencies procure pharmaceutical products under this code family, including vaccines and diagnostic reagents. The scope of work encompasses sole source and competitive acquisition of pharmaceuticals needed for public health programs, disease prevention, and clinical laboratory operations.

The Mississippi State Department of Health posted a sole source notice (Solicitation 3150006922, 1301-27-R-RFIN-00001) on July 13, 2026, for Yellow Fever Vaccine from Sanofi Pasteur, Inc., with an objections deadline of August 3, 2026. The notice permits any person or entity to challenge the sole source classification by submitting written objections with supporting evidence of alternative suppliers to Cynthia Brasher, Mississippi State Department of Health Purchasing Department, by hand delivery, mail, overnight carrier, or email at Cynthia.brasher@msdh.ms.gov. If substantiated objections are received, the department will conduct a competitive bid process; if the department sustains the sole source finding, it must appeal to the Public Procurement Review Board and prove exclusive availability from Sanofi Pasteur. The notice did not specify quantity, contract term, estimated value, or pricing.